autosomal recessive nonsyndromic hearing loss 39
autosomal recessive nonsyndromic hearing loss 39
Explore linked clinical trials. Standard reference: MONDO:00120033 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, autosomal recessive nonsyndromic hearing loss 39, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT04077099 | |
| Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury | autosomal recessive nonsyndromic hearing loss 39 | Not yet recruiting | Phase 3 | 2026-07-23 | NCT07722962 | |
| Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar | autosomal recessive nonsyndromic hearing loss 39 | Active, not recruiting | Phase 3 | 2026-07-06 | NCT05627648 |